Skip to main content

Biomerica Inc

BMRA
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
SEC CIK
0000073290

In the last 90 days, Biomerica Inc insiders filed 5 open-market purchases and 0 sales; 20 institutions reported holding it in 13F filings for Q2 2026, worth $220.0K in total; no superinvestor holds it.

Q1 2025 vs. Q4 2024

How the institutions holding Biomerica Inc changed between Q4 2024 and Q1 2025.

All holders in Q1 2025All holders in Q4 2024

13F holders of BMRA: Q4 2024 compared with Q1 2025
MeasureQ4 2024Q1 2025Change
Holders2124+3
Shares1.41M959.7K−446.8K (−31.8%)
Value$420.8K$542.9K+$122.1K (+29.0%)

New holders (6)

Institutions that held Biomerica Inc at the end of Q1 2025 but not at the end of Q4 2024.

Institutions new to BMRA in Q1 2025
InstitutionSharesValue% of portfolio
Bulltick Wealth Management, LLC137,149$77.8K0.02%
Two Sigma Investments, LP42,362$24.0K0.00%
NewEdge Wealth, LLC10,000$5.67K0.00%
Advisor Group Holdings, Inc.3,000$1.71K0.00%
SBI Securities Co., Ltd.20$110.00%
Simplex Trading, LLC1,478$00.00%

Sold out (3)

Institutions that held Biomerica Inc at the end of Q4 2024 and filed for Q1 2025 without it.

Institutions that sold out of BMRA in Q1 2025
InstitutionShares, Q4 2024Value, Q4 2024
XTX Topco Ltd19,247$5.78K
Virtu Financial LLC17,763$5.00K
Cambridge Investment Research Advisors, Inc.10,125$3.00K